Regeneron (REGN) Tops Q1 EPS by 53c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $659.80 -2.28%
Revenue Growth %: +3.3%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
CSHX, FFBB, WRIV, More
Revenue Growth %: +3.3%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
CSHX, FFBB, WRIV, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $10.09, $0.53 better than the analyst estimate of $9.56. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Reiterates Buy Rating on Porch Group Inc. (PRCH) on Improved Position From 6 Months Ago
- Cashmere Valley Bank (CSHX) Tops Q2 EPS by 188c
- Regeneron Pharma (REGN) PT Raised to $1,000 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
